BioCentury
ARTICLE | Company News

J&J other, pharmaceuticals news

March 9, 2015 7:00 AM UTC

Johnson & Johnson launched the fourth incubator in its JLABS network, located in South San Francisco, and named the first 10 companies in residence. J&J said the incubator can accommodate up to 50 startups.

Eight of the 10 are therapeutics companies, including Applied Molecular Transport LLC, which has granted the pharma’s Janssen Biotech Inc. unit exclusive, worldwide rights to a preclinical candidate to treat inflammatory bowel disease (IBD) (see BioCentury, Feb. 2). ...